Bain Capital Life Sciences Investors, LLC - NUVALENT INC ownership

NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 100 filers reported holding NUVALENT INC in Q4 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.5%.

Quarter-by-quarter ownership
Bain Capital Life Sciences Investors, LLC ownership history of NUVALENT INC
ValueSharesWeighting
Q3 2023$164,446,964
+9.0%
3,577,2670.0%18.39%
+18.4%
Q2 2023$150,853,349
+161532.6%
3,577,2670.0%15.54%
+33.2%
Q1 2023$93,331
-12.4%
3,577,2670.0%11.66%
-2.0%
Q4 2022$106,531
-99.8%
3,577,267
+4.4%
11.90%
+49.7%
Q3 2022$66,641,000
+43.4%
3,428,0140.0%7.96%
+45.9%
Q2 2022$46,484,000
-2.4%
3,428,0140.0%5.45%
+17.9%
Q1 2022$47,615,000
-27.0%
3,428,0140.0%4.62%
-10.6%
Q4 2021$65,269,000
-15.6%
3,428,0140.0%5.18%
+7.9%
Q3 2021$77,302,0003,428,0144.80%
Other shareholders
NUVALENT INC shareholders Q4 2022
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 19,341,024$436,140,0008.51%
Fairmount Funds Management LLC 914,614$20,625,0007.50%
Bain Capital Life Sciences Investors, LLC 3,428,014$77,302,0004.80%
VR Adviser, LLC 803,951$18,129,0002.33%
Boxer Capital, LLC 1,210,192$27,290,0000.95%
BVF INC/IL 448,512$10,114,0000.40%
Avoro Capital Advisors LLC 1,257,671$22,288,0000.35%
DRIEHAUS CAPITAL MANAGEMENT LLC 1,052,394$23,731,0000.28%
Perceptive Advisors 750,000$16,913,0000.25%
Logos Global Management LP 134,650$2,733,0000.20%
View complete list of NUVALENT INC shareholders